echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > CELL: TBL1XR1 mutation drives the occurrence of extra-end node lymphoma?

    CELL: TBL1XR1 mutation drives the occurrence of extra-end node lymphoma?

    • Last Update: 2020-07-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The most aggressive B-cellslymphomaoften manifest themselves as body cell mutations that are present in vitro distribution and carry the TBL1XR1 gene, which are not characterized ablyrecently, researchers showed that the TBL1XR1 mutation tends toimmunereactions in body fluids toward the production of abnormal immature memory B cells (MB) while impairing plasma cell differentiationat the molecular level, the TBL1XR1 mutant works with the SMRT/HDAC3 inhibitor complex, combining MB cell transcription factor (TF) BACH2, while sacrificing the reproductive center (GC) transcription factor BCL6, resulting in pre-memory transcription reprogramming and cell destiny deviationantigen recovery, TBL1XR1 mutant MB cells cannot differentiate into plasma cells, but prioritize re-entry into new GC reactions, providing evidence for the mechanism of cyclic re-entry into lymphatic occurrenceeventually, the change in TBL1XR1 led to an amazing epigenetic immune cell lymphoma phenotype that mimicked human diseaseand mouse lymphoma have expanded MB-like cell populations that are consistent with the origin of MB cells and reveal unforeseen pathways to malignant transformation of the immune system
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.